© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Use of the nucleoside reverse transcriptase inhibitor (NRTI) abacavir is not associated with an increased risk of a heart attack or stroke.
Nurses in South Africa perform just as well as doctors in terms of monitoring people living with HIV receiving antiretroviral (ARV) therapy
Acyclovir doesn’t prevent HIV-positive people from transmitting the virus to their uninfected partners, but it does appear to slow HIV disease...
People taking a regimen including Sustiva (efavirenz) appeared to have greater limb fat loss and gut fat accumulation than those on Kaletra (l...
Nearly half of a group of HIV-positive men in New York City had abnormally low levels of vitamin D—potentially leaving them at risk for...
HIV-positive women may experience menopause at a younger age than their HIV-negative counterparts, according to a study presented at the Fifth...
Once-daily Kaletra (lopinavir/ritonavir) dosing may be an option for treatment-experienced people living with HIV, according to study results...
Chronic stress may increase the risk of non-AIDS, age-related health problems in people living with HIV, according to a team of Spanish resear...
People whose virus is well controlled by a regimen containing Norvir (ritonavir)-boosted Reyataz (atazanavir) can drop the Norvir—while...
Switching to Norvir-boosted Prezista monotherapy after achieving an undetectable viral load using combination ARV treatment worked well
There were no HIV transmissions and few birth defects in the babies of HIV-positive African women who were treated with ARV therapy.
A quadruple combination of four similar drugs from the same class—Truvada (tenofovir plus emtricitabine), Retrovir (zidovudine) and Ziag...
A daily supplement including key vitamins and minerals showed promise for increasing survival in Ugandan children living with HIV, according t...
HIV-positive children exposed to single-dose Viramune (nevirapine) at birth are more likely to have virologic success later with a Kaletra (lo...
People on a regimen containing either once or twice daily Viramune (nevirapine) were as able as people on a Norvir (ritonavir)?boosted Reyataz...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.